Recall Record

Saint Cloud, MN, United States

Microbiologics Inc recalls

41 recalls recorded since 2018, most recently on 2 December 2025. 14 are listed as ongoing. Status and classification are as published by the FDA.

Recalls41
Ongoing (FDA)14
Terminated or completed27
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
2 December 2025
Reason
Affected units may fail to recover the target microorganism Campylobacter jejuni subsp. jejuni derived from ATCC 29428.
Distribution
Worldwide - US Nationwide.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0984-2026, Z-0985-2026, Z-0986-2026

Ongoing Class II Medical devices

Recall started
13 November 2025
Reason
Some products packaged for lot 818-111-7 may have been packaged in pouches labeled as lot 857-53-10.
Distribution
International distribution to the countries of UAE, China, Singapore, Kazakhstan,
Initiated
Voluntary: Firm initiated
Recall number
Z-0876-2026

Ongoing Class II Medical devices

Recall started
27 June 2025
Reason
KWIK-STIK REF numbers: 0894P, 0894K and LYFO DISK" 0894L may result in failure to recover the target microorganism. All lots of REF 894-76 are impacted.
Distribution
Worldwide distribution - US Nationwide and the countries of France, Colombia, Philippines, Peru, Turkey, India, Finland, Trinidad and Tobago, Poland, Viet Nam, Brazil, Japan, Malaysia, Costa Rica.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2194-2025, Z-2195-2025

Ongoing Class II Medical devices

Recall started
17 June 2025
Reason
Affected products contain Staphylococcus epidermidis instead of the expected Brevundimonas diminuta. This may cause the user's quality control to fail and delayed diagnosis for the patient.
Distribution
US distribution to states of: Utah and Ohio; and OUS (International) to countries of: Italy, Netherlands, Argentina, Korea, Jordan, Spain, and Bangladesh.
Initiated
Voluntary: Firm initiated
Recall number
Z-2124-2025

Ongoing Class II Medical devices

Recall started
27 May 2025
Reason
Affected products were packaged with the incorrect KWIK STIK assembly resulting in the product containing the wrong microorganism. 0621K was packaged 01065K swabs; 01065K was packaged with 0621K swabs. This may lead to delayed diagnosis.
Distribution
US Nationwide distribution in the states of California and Pennsylvania and the country of New Zealand.
Initiated
Voluntary: Firm initiated
Recall number
Z-1957-2025

Ongoing Class II Medical devices

Recall started
20 February 2025
Reason
The A549 human cell target (human cells for sample adequacy control) may give a late Ct value.
Distribution
US Nationwide distribution in the states of TX. UK.
Initiated
Voluntary: Firm initiated
Recall number
Z-1371-2025

Ongoing Class II Medical devices

Recall started
20 February 2025
Reason
The RSV target may give a late Ct value and could potentially not pass QC.
Distribution
Worldwide - US Nationwide distribution in the states of KY, MT, NJ, NY, WI and the countries of Ireland, Germany, UK.
Initiated
Voluntary: Firm initiated
Recall number
Z-1454-2025

Ongoing Class II Medical devices

Recall started
20 January 2025
Reason
Internal quality control procedures were not followed correctly for the testing/release of three lots of 8234/8235. This resulted in the release of products that should have failed and been discarded. The concentration of one target (HPV 16 L1) was low enough to cause QC failures, no detection, or invalid results on some instruments and assays.
Distribution
Worldwide distribution - US Nationwide and the countries of Netherlands, Sweden, UK, France, Australia, New Zealand.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1163-2025, Z-1164-2025

Ongoing Class II Medical devices

Recall started
6 March 2024
Reason
The positive control material (Rhizopus stolonifer) within the KWIK-STIK assembly was contaminated with another fungal organism (Aspergillus brasiliensis). As a result, users may observe A. brasiliensis growth when using the control material.
Distribution
Worldwide - US Nationwide distribution in the states of CA, MI, KY, MO, NM, TN, PR, and the countries of France, Columbia, Kazakhstan, Peru, Puerto Rico, South Africa.
Initiated
Voluntary: Firm initiated
Recall number
Z-1483-2024

Ongoing Class II Medical devices

Recall started
8 January 2024
Reason
The negative control was contaminated with one of the positive control pathogens (Norovirus). This would result in users getting a positive call for Norovirus when running the negative control.
Distribution
US Nationwide distribution in the states of AL, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, MA, MI, MN, MO, MS, MT, NE, NH, NJ, NY, OH, PA, RI, TN, TX, VA, WA, WI, WV, and WY. There was government distribution and no military distribution. Foreign distribution was made to France.
Initiated
Voluntary: Firm initiated
Recall number
Z-1075-2024

Ongoing Class II Medical devices

Recall started
18 October 2023
Reason
A complaint investigation showed that the bulk pellets (lot 794-142) were contaminated with Aspergillus flavus.
Distribution
Worldwide distribution - US Nationwide and the countries of Italy, France, Turkey, Peru, Mexico.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0307-2024, Z-0308-2024

Ongoing Class III Medical devices

Recall started
14 August 2023
Reason
One lot of KWIK STIK ANA (3 strains) QC Set is missing one of the strains, 6018P Parabacteroides distasonis.
Distribution
US Nationwide distribution in the states of MN, PA, TN, TX.
Initiated
Voluntary: Firm initiated
Recall number
Z-2576-2023

Terminated Class III Medical devices

Recall started
27 July 2022
Terminated
2 August 2024
Reason
Product not registered for use in the UK
Distribution
International distribution to the country of United Kingdom.
Initiated
Voluntary: Firm initiated
Recall number
Z-1740-2022

Terminated Class III Medical devices

Recall started
6 May 2022
Terminated
16 January 2024
Reason
Labeling error.
Distribution
Distributed US Nationwide to IA, TN and internationally to Mexico, Colombia, France, South Africa, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall number
Z-1125-2022

Terminated Class II Medical devices

Recall started
24 March 2022
Terminated
9 January 2023
Reason
QC process was not adequate for the specification range.
Distribution
US Nationwide distribution in the state of TX.
Initiated
Voluntary: Firm initiated
Recall number
Z-0954-2022

Terminated Class II Medical devices

Recall started
22 March 2022
Terminated
9 January 2023
Reason
The QC process was not adequate for the specification range.
Distribution
US Nationwide distribution in the states of NV and VT.
Initiated
Voluntary: Firm initiated
Recall number
Z-0955-2022

Terminated Class II Medical devices

Recall started
3 March 2022
Terminated
16 January 2024
Reason
Shelf-life for the 8244 Pneumonia (33 Targets) Control Panel determined to be 6 months instead of 18 months.
Distribution
US distribution to Alabama, Georgia, Illinois, Montana, Pennsylvania, Tennessee, Texas, and Wisconsin
Initiated
Voluntary: Firm initiated
Recall number
Z-0844-2022

Terminated Class II Medical devices

Recall started
25 February 2022
Terminated
16 January 2024
Reason
Distributed product did not undergo proper release testing.
Distribution
Distribution in US: AZ, CT, DC, FL, IL, IN, KS, KY, MA, MD, NC, NH, NJ, NY, PA, TX, UT, WA OUS distribution to Belgium, Finland, France, Germany, Ireland, Sweden, United Kingdom, and Vietnam
Initiated
Voluntary: Firm initiated
Recall number
Z-0784-2022

Terminated Class II Medical devices

Recall started
20 August 2021
Terminated
12 January 2023
Reason
The SARS-CoV-2 Process Control (Pellet) contains RNA transcripts that include diagnostically relevant SARS-CoV-2 targets (CDC and WHO consensus sequences).
Distribution
Worldwide distribution - US Nationwide distribution in the states of CA, FL, GA, IL, MD, MT, MN, NC, NY, NV, OR, TN, TX,UT, WA and WI. The countries of Austria, Canada, Colombia, France, Germany, Hong Kong, India, Ireland, Italy, Japan and United Kingdom.
Initiated
Voluntary: Firm initiated
Recall number
Z-2486-2021

Terminated Class II Medical devices

Recall started
20 August 2021
Terminated
12 January 2023
Reason
The product indicated is contaminated with a plasmid DNA that contains the target SARS-CoV-2 sequences.
Distribution
Worldwide distribution - US Nationwide distribution in the states of CA, FL, GA, IL, MD, MT, MN, NC, NY, NV, OR, TN, TX,UT, WA and WI. The countries of Austria, Canada, Colombia, France, Germany, Hong Kong, India, Ireland, Italy, Japan and United Kingdom.
Initiated
Voluntary: Firm initiated
Recall number
Z-2487-2021

Terminated Class III Medical devices

Recall started
24 February 2021
Terminated
11 July 2022
Reason
Potential of products packaged for lot 323-108-7 were packaged in pouches labeled as 726-57-10.
Distribution
US distribution to CA, FL, HI, MI, NC, NH, NJ, OK, OR, TN. International distribution to Canada, Ecuador, France, India, Indonesia, Ireland, Japan, Mexico, South Africa, United Arab Emirates, Vietnam.
Initiated
Voluntary: Firm initiated
Recall number
Z-0544-2022

Terminated Class III Medical devices

Recall started
24 February 2021
Terminated
11 July 2022
Reason
Potential that products packaged for lot 726-57-10 were packaged in pouches labeled as 323-108-7.
Distribution
Worldwide distribution - US distribution in the states of GA, MS, MT, NC, NM, NV, TN, TX, WA, WI and the countries of Brazil, Canada, China, Colombia, Dominican Republic, France, India, Ireland, Japan, Mexico, Oman, Philippines, Romania, South Africa, Turkey, United Arab Emirates.
Initiated
Voluntary: Firm initiated
Recall number
Z-0543-2022

Terminated Class III Medical devices

Recall started
16 December 2020
Terminated
12 January 2023
Reason
The expiration date on the label of one component (negative control 0243U) in the set lot is incorrectly labeled. The KWIK-STIK negative control 0243U was labeled with an expiration date of 7/31/2020 when it should have been 7/31/2022.
Distribution
US Nationwide distribution in the states of AL, CA, CO, IL, MD, MO, MS, NM, OH, OR, PA, TX, VT.
Initiated
Voluntary: Firm initiated
Recall number
Z-0546-2022

Terminated Class II Medical devices

Recall started
16 December 2020
Terminated
7 July 2022
Reason
Contamination with S. epidermidis
Distribution
Distribution was made to CA, IA, IL, LA, MA, MI, NY, PA, SD, TN, VA, WI, and WV. There was no government/military distribution. Foreign distribution was made to Brazil, Canada, Colombia, Dominican Republic, Finland, France, India, Japan, Malaysia, Mexico, Netherlands, Poland, Romania, Saudi Ar
Initiated
Voluntary: Firm initiated
Recall number
Z-0511-2022

Terminated Class II Medical devices

Recall started
8 October 2020
Terminated
3 November 2022
Reason
Strain should be VIM-1 positive but is confirmed to be VIM-1 negative.
Distribution
Worldwide distribution - US Nationwide distribution and the countries of Austria, Canada, Chile, China, Germany, India, Ireland, Japan, Philippines, United Kingdom, and Vietnam.
Initiated
Voluntary: Firm initiated
Recall number
Z-0402-2021

Terminated Class II Medical devices

Recall started
8 October 2020
Terminated
17 November 2022
Reason
KWIK-STIK 6 Pack Klebsiella pneumoniae derived from NCTC 13443 (Catalog# 01145K) should contain the NDM-1 positive strain, but was confirmed to be NDM-1 negative.
Distribution
Distribution in US, Brazil, Canada, Costa Rica, France, Germany, Ireland, Italy, Japan, New Zealand, Sweden, and United Kingdom.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0303-2021, Z-0302-2021, Z-0304-2021

Terminated Class III Medical devices

Recall started
8 October 2020
Terminated
7 July 2022
Reason
The incorrect lot number was printed on the foil pouch that the KWIK-STIK" is placed in. All foil pouches for lot 318-234-4 have the lot number misprinted as 218-234-4. The correct lot number was printed on the KWIK-STIK" canister label and KWIK-STIK" device label.
Distribution
US distribution to . International distribution to Austria, Botswana, Brazil, Canada, China, Colombia, Finland, France, Germany, Guatemala, India, Indonesia, Ireland, Israel, Italy, Japan, Jordan, Korea, Republic of, Lithuania, Malaysia, Mauritius, Netherlands, Norway, Oman, Peru, Poland, Romania
Initiated
Voluntary: Firm initiated
Recall number
Z-0581-2022

Terminated Class II Medical devices

Recall started
1 October 2020
Terminated
7 July 2022
Reason
Potential contamination with S. epidermidis E. coli and S. warneri.
Distribution
Worldwide distribution - US Nationwide distribution in the states of AR, AZ, CA, CO, DE, FL, GA, IA, IL, IN, KS, LA, MA, MD, ME, MI, MN, MS, MT, NC, ND, NE, NM, NY, OH, OK, OR, PR, SC, TN, TX, VA, VT, WA, WV and the countries of AUSTRALIA, AUSTRIA, BAHRAIN, BELARUS, BELGIUM, BRAZIL, CANADA, CHILE, C
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0582-2022, Z-0584-2022, Z-0583-2022

Terminated Class II Medical devices

Recall started
18 February 2020
Terminated
11 July 2022
Reason
Tests returning incorrect susceptible results. High Level Gentamicin Synergy value was out of specification (sensitive) when analyzed on the Vitek 2 AST-GP67 card, and these lots failed the disk diffusion method used for product release.
Distribution
Worldwide Distribution. US nationwide including Puerto Rico and Guam, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Costa Rica, Croatia/Hrvatska, Curacao, Denmark, Ecuador, Egypt, El Salvador, Finland, France, Germany, Guatemala, Hong Kong, India, Ireland, Israel, Italy, Japa
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0587-2022, Z-0589-2022, Z-0586-2022, Z-0588-2022, Z-0585-2022

Terminated Class II Medical devices

Recall started
12 February 2020
Terminated
26 March 2021
Reason
KWIKSTIK 2 Pack (REF 0778P) and QC Set and Panels: KWIKSTIK YST Comprehensive QC Set (REF 5195P) contain product labeled as Trichosporon dermatis (T. dermatis) which may contain Candida Utilis instead of T. dermatis.
Distribution
Nationwide, Including Australia, Brazil, Curacao, Ecuador, Germany, Greece, Italy, Puerto Rico, Singapore, Turkey, United States, Uruguay and Australia.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1691-2020, Z-1690-2020

Terminated Class II Medical devices

Recall started
3 January 2020
Terminated
16 September 2020
Reason
Product 8208 Vaginal Verification Panel is a 6 pool kit and has contaminant Candida krusei in Pool 2 (subcomponent 6063). Candida krusei is an organism intended to be contained in Pool 6 of the kit. This should have no impact on patient test results as long as Gardnerella vaginalis was properly detected when using Pool 2 and/or users are strictly using this product for instrument verification/validation.
Distribution
Distributed in the US to 7 states: CA, KS, ME, NC, NY, OR, and UT. No Canada, Mexico or VA.
Initiated
Voluntary: Firm initiated
Recall number
Z-1096-2020

Terminated Class II Medical devices

Recall started
16 December 2019
Terminated
11 December 2020
Reason
The recommended hydration fluid for the 8180 Gram-Positive Blood Culture Control Panel (Inactivated Pellet), has changed from sterile 0.85% saline or sterile blood culture media to sterile DI water or pH 7.2 phosphate buffer.
Distribution
Distributed nationwide including Washington DC, and distributed internationally to Germany and Netherlands.
Initiated
Voluntary: Firm initiated
Recall number
Z-0812-2020

Ongoing Class III Medical devices

Recall started
16 May 2019
Reason
Product is labeled with expiration date of 2021-10-31, should be 2021-03-31.
Distribution
NY, MN, NC, TX, GA, MO, PA, TN, NH, OH, CO
Initiated
Voluntary: Firm initiated
Recall number
Z-1838-2019

Ongoing Class II Medical devices

Recall started
9 April 2019
Reason
Product with incorrect shelf life.
Distribution
Worldwide Distribution - US Nationwide AL, AR, AZ, CA, CO, CT, FL, GA, IA, ID, IL, IN, KS, KY, MA, MD, MI, MO,MS, MT, NC, ND, NJ, NY, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WV, and WY. Australia, Chile, Germany, New Zealand, and United Kingdom.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1730-2019, Z-1731-2019

Terminated Class II Medical devices

Recall started
31 January 2019
Terminated
9 June 2020
Reason
Cepheid Xpert Respiratory Control Panel (Catalog #8199) has an reduced expiration date from 24 months to 13 months.
Distribution
Nationwide distribution to AK, AL, AR, AZ, CA, CO, CT, FL, GA, IA, ID, IL, IN, KS, LA, MA, MD, ME, MI, MN, MO, NC, NH, NJ, NY, OH, OK, OR, PA, TN, TX, UT, VA, VT, WA, WI, WV. International distribution to Austria, Canada, Finland, Ireland, Malaysia, New Zealand, Portugal, South Africa, Sweden
Initiated
Voluntary: Firm initiated
Recall number
Z-0982-2019

Terminated Class II Medical devices

Recall started
6 June 2017
Terminated
17 January 2023
Reason
Real-time shelf life testing failed at 24 months
Distribution
Worldwide distribution - US Nationwide distribution in the states of AK, CA, DC, FL, IA, ID, KS, LA, MD, MN, MO, NE, NH, NJ, NY, OH, OK, PA, SC, TX, VA, WA, WV and the countries of Australia, Belgium, Canada, India, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0697-2022, Z-0700-2022, Z-0699-2022, Z-0698-2022, Z-0701-2022

Terminated Class III Medical devices

Recall started
2 March 2017
Terminated
22 April 2022
Reason
Potential for product labeled as Actinomyces odontolyticus is actually Eggerthella lenta.
Distribution
International distribution in the countries of Canada and Germany.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0637-2022, Z-0636-2022

Terminated Class II Medical devices

Recall started
1 December 2015
Terminated
7 July 2022
Reason
The Lactobacillus acidophilus negative control (item 0243 single KWIK-STIK) contained in the 8164 Cepheid Xpert GBS QC Set and 8165 Cepheid Smart GBS QC Set was found to test positive for Group B Streptococcus (GBS) in some cases. This causes a failure when used as a quality control for the Cepheid Xpert GBS and Cepheid Smart GBS systems. The failure of the quality control test causes a disruption for the testing laboratory which may result in repeated testing or the need for alternative test methods. This recall is applicable to the 8164 and 8165 sets only.
Distribution
US Nationwide distribution in the states of AZ, CA, CO, FL, GA, HI, IA, IL, IN, KS, LA, MA, MD, MN, NC, NM, NY, OH, OR, PA, TN, TX, VA, VT, WA, WI, WV, WY.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0704-2022, Z-0703-2022

Completed Class III Medical devices

Recall started
17 July 2015
Reason
LYFO Disk Catalog #0983L is to contain Candida tropicalis. However, lot number 983-40-3 under Catalog #0983L, labeled as Candida tropicalis, is actually Yersinia entercolitica. This labeling error may cause a user's quality control to fail, resulting in testing needing to be repeated and delayed test results.
Distribution
Distribution is nationwide with three consignees located in Colorado, Georgia, and Ohio.
Initiated
Voluntary: Firm initiated
Recall number
Z-0788-2022

Terminated Class II Medical devices

Recall started
6 October 2014
Terminated
17 January 2023
Reason
This strain should be resistant to high levels of Gentamicin and be resistant to Gentamicin Synergy. A specific lot was found susceptible to Gentamicin Synergy during in-house testing.
Distribution
Worldwide distribution - US Nationwide and the countries of Argentina, Belgium, Brazil, Canada, Chile, China, Colombia, Croatia/Hrvatska, Ecuador, Finland, France, Germany, Guam, Guatemala, Hong Kong, India, Ireland, Israel, Italy, Japan, Kenya, Republic of Korea, Latvia, Macedonia, Malaysia, Nether
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0714-2022, Z-0712-2022, Z-0713-2022

Terminated Class III Medical devices

Recall started
25 March 2013
Terminated
22 April 2022
Reason
Some of the KWIK-STIK Catalog #01023P Campylobacter coli, Lot# 1023-05-7, contained an inner label stating the product is Catalog #0919K Haemophilus influenza. The organism has been confirmed to be C. coli, indicating this is a labeling error and the organism is the correct organism.
Distribution
Worldwide distribution - US Nationwide and the countries of Canada, South Africa, France, Netherlands, Mauritius, China.
Initiated
Voluntary: Firm initiated
Recall number
Z-0641-2022

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.